Testimony to the FDA’s Advisory Committee on Reproductive Health Drugs on gabapentin for menopausal symptoms
March 4, 2013
View as PDF.
View press release
Public Citizen strongly opposes the Food and Drug Administration’s
(FDA’s) approval of gabapentin for treatment of menopause-related vasomotor
symptoms (VMS, which includes hot flashes and flushing) due to the drug's
questionable benefits and well-established risks.